BREAKING NEWS! 01/13/2021 FDA Impressed with Gamma Human Studies

Using specific frequencies of flashing lights and sounds to stimulate the brain’s electrical activity, MIT believes 40Hz Gamma, delivered via the visual and auditory channels, can help treat Alzheimer’s disease by energizing neurons and reactivating the immune system.


The daily treatment has shown positive effects in mice, with changes in the brain’s hippocampus and auditory cortex including the reduction of amyloid plaques, according to a study published in medical journal Cell.


Now, with the treatment approach being studied in placebo-controlled human trials, the FDA said it has seen enough early clinical data to label the device as a potential breakthrough therapy.


Why wait?
Enjoy and benefit from this research now, with Auragen!